-
Orbit Genomics Wins Startup Prize Focus on Health (Non-FDA Track)
Orbit Genomics today announced that it is the grand prize winner of the Startup Prize Focus on Health 2025 in the Non-FDA track, a nationally recognized competition spotlighting transformative innovation in healthcare and life sciences. Selected from a record-breaking pool of 75 startups across 23 states, Orbit Genomics was recognized for its patented OrbiSeq™ platform,…
-
Orbit Genomics Appoints Accomplished Laboratory Director Angie Purvis to Broaden Diagnostic Expertise
Orbit Genomics, a pioneer in redefining precision medicine, today announced the appointment of Angie Purvis as Laboratory Director. With over 15 years of leadership in high-complexity molecular, immunological, and clinical chemistry laboratories, Purvis brings deep expertise in laboratory-developed tests (LDTs), regulatory compliance, and diagnostic innovation to the Orbit team. “Angie’s track record in building high-quality,…
-
Orbit Genomics Appoints Renowned Life Sciences Attorney Vern Norviel to Advisory Board
Orbit Genomics, a pioneer in redefining precision medicine, today announced the appointment of Vern Norviel, JD, MS, to its Advisory Board. A highly respected attorney and strategist in biotechnology and intellectual property law, Norviel brings decades of experience advising companies and investors at the forefront of life science innovation. “Vern’s rare ability to blend deep…